Template:Tinea management: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
''Coverage for Trichophyton and Epidermophyton'' and all treatment should be at lease 1 week past resolution of lesions | ''Coverage for Trichophyton and Epidermophyton'' and all treatment should be at lease 1 week past resolution of lesions | ||
===Topical Therapy=== | ===Topical Therapy=== | ||
'''Applies to [[Tinea corporis]], [[Tinea pedis|pedis]], [[Tinea cruris|cruris]], and [[Tinea manus|manus]] ''' | |||
Must use a topical therapy for 7-10days beyond resolution of lesions | |||
*Topical antifungal treatment for all except tinea capitis | *Topical antifungal treatment for all except tinea capitis | ||
*[[Terbinafine]] 1% BID x2-3weeks or | *[[Terbinafine]] 1% BID x2-3weeks or | ||
*[[Clotrimazole]] 1% BID x2-3weeks or | *[[Clotrimazole]] 1% BID x2-3weeks or | ||
*[[Ketoconazole]] 1% BID x2-3weeks | *[[Ketoconazole]] 1% BID x2-3weeks | ||
===Capitis=== | ===Capitis=== | ||
*[[Griseofulvin]] 500mg-1000mg PO once daily (20-25mg/kg/d) | |||
**Usually requires 8wk of treatment | |||
*[[Terbinafine]] for 2-4 weeks is as effective of 6-8 weeks of [[griseofulvin]]<ref>Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114(5):1312-1315. doi:10.1542/peds.2004-0428</ref> | |||
**62.5mg/day in children <20kg | |||
**125mg/day in children 20-40kg | |||
**250mg/day in children >40kg<ref>Andrews MD, Burns M: Common tinea infections in children. Am Fam Physician 2008;77(10):1415-1420.</ref> | |||
*[[Selenium sulfide]] or [[ketoconazole]] shampoos are adjunct treatment | |||
* | *Children can return to school during treatment | ||
=== | |||
===Kerion=== | |||
*Oral griseofulvin, itraconazole, or terbinafine for 6-8 wks<ref>Gnanasegaram M. Kerion. DermNet NZ. 2012. http://www.dermnetnz.org/fungal/kerion.html</ref> | |||
*[[Cephalexin]] 40mg/kg/d in 4 divided doses in addition to systemic antifungal treatment if there is evidence or high risk of bacterial secondary infection | |||
*Ketoconazole shampoo, isolated towels decrease spread to household members | |||
===[[Tinea corporis]]=== | ===[[Tinea corporis]]=== | ||
First line should be topical therapy. For refractory cases or severe bullous disease the below anti-fungals are all equivalent options. | First line should be topical therapy. For refractory cases or severe bullous disease the below anti-fungals are all equivalent options. | ||
Latest revision as of 07:01, 12 February 2023
Coverage for Trichophyton and Epidermophyton and all treatment should be at lease 1 week past resolution of lesions
Topical Therapy
Applies to Tinea corporis, pedis, cruris, and manus
Must use a topical therapy for 7-10days beyond resolution of lesions
- Topical antifungal treatment for all except tinea capitis
- Terbinafine 1% BID x2-3weeks or
- Clotrimazole 1% BID x2-3weeks or
- Ketoconazole 1% BID x2-3weeks
Capitis
- Griseofulvin 500mg-1000mg PO once daily (20-25mg/kg/d)
- Usually requires 8wk of treatment
- Terbinafine for 2-4 weeks is as effective of 6-8 weeks of griseofulvin[1]
- 62.5mg/day in children <20kg
- 125mg/day in children 20-40kg
- 250mg/day in children >40kg[2]
- Selenium sulfide or ketoconazole shampoos are adjunct treatment
- Children can return to school during treatment
Kerion
- Oral griseofulvin, itraconazole, or terbinafine for 6-8 wks[3]
- Cephalexin 40mg/kg/d in 4 divided doses in addition to systemic antifungal treatment if there is evidence or high risk of bacterial secondary infection
- Ketoconazole shampoo, isolated towels decrease spread to household members
Tinea corporis
First line should be topical therapy. For refractory cases or severe bullous disease the below anti-fungals are all equivalent options.
- Fluconazole 150mg (6mg/kg) PO once a week x 2 weeks or
- Itraconazole 200mg (5mg/kg) PO daily q12hrs for 1 week or
- Griseofulvin 500-1000mg (20mg/kg) PO daily for 2-4 weeks
- ↑ Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114(5):1312-1315. doi:10.1542/peds.2004-0428
- ↑ Andrews MD, Burns M: Common tinea infections in children. Am Fam Physician 2008;77(10):1415-1420.
- ↑ Gnanasegaram M. Kerion. DermNet NZ. 2012. http://www.dermnetnz.org/fungal/kerion.html